CONIGLIARO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 18.998
EU - Europa 1.603
AS - Asia 1.044
OC - Oceania 12
AF - Africa 5
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.671
Nazione #
US - Stati Uniti d'America 18.971
SG - Singapore 583
CN - Cina 322
IT - Italia 312
IE - Irlanda 274
DE - Germania 203
UA - Ucraina 197
RU - Federazione Russa 160
FR - Francia 157
GB - Regno Unito 101
FI - Finlandia 69
KR - Corea 62
SE - Svezia 41
PL - Polonia 27
BE - Belgio 24
CA - Canada 20
VN - Vietnam 19
IN - India 12
AU - Australia 11
IR - Iran 11
HK - Hong Kong 10
AT - Austria 9
UZ - Uzbekistan 9
MX - Messico 7
ES - Italia 5
RO - Romania 5
BR - Brasile 4
ID - Indonesia 4
NL - Olanda 4
SI - Slovenia 4
BD - Bangladesh 3
DK - Danimarca 3
JP - Giappone 3
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
MA - Marocco 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BJ - Benin 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
IL - Israele 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.671
Città #
Wilmington 5.505
Houston 4.783
Woodbridge 4.462
Fairfield 634
Ann Arbor 527
Singapore 513
Chandler 426
Ashburn 325
Seattle 247
Dublin 229
Cambridge 212
Medford 175
Jacksonville 150
Santa Clara 124
New York 120
Rome 118
Beijing 93
Dearborn 87
Lawrence 82
Zhengzhou 59
Redwood City 49
Moscow 40
San Diego 36
Seoul 28
Boardman 27
Kraków 27
Menlo Park 27
Chengdu 26
Nanjing 24
Brussels 23
Los Angeles 23
London 20
Shenzhen 19
Dong Ket 18
Helsinki 18
Mülheim 16
Shanghai 15
Toronto 15
Palo Alto 14
Norwalk 13
Bassano del Grappa 12
Hefei 12
Lappeenranta 12
Leawood 12
Milan 12
Augusta 11
Center 11
Mountain View 11
Kunming 10
Las Vegas 9
The Dalles 9
Buffalo 8
Council Bluffs 8
Guangzhou 8
Hong Kong 8
Phoenix 8
San Mateo 8
Scottsdale 8
Esslingen am Neckar 7
Del Norte 6
Mexico City 6
Nuremberg 6
San Francisco 6
Chicago 5
Padova 5
Sydney 5
Williamsburg 5
Wuhan 5
Ardabil 4
Aversa 4
Bologna 4
Brisbane 4
Durham 4
Falls Church 4
Fuzhou 4
Jinan 4
Kilburn 4
Napoli 4
Novi Velia 4
Perugia 4
Pune 4
Redmond 4
Abbadia San Salvatore 3
Acton 3
Baotou 3
Changsha 3
Chieti 3
Dhaka 3
Hounslow 3
Indiana 3
Livorno 3
Melfa 3
Montreal 3
Munich 3
Nanchang 3
Rensselaer 3
San Jose 3
Shenyang 3
St. George 3
Surabaya 3
Totale 19.692
Nome #
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 488
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 458
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 449
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 434
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 432
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 431
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 420
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 418
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 416
Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. 414
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 409
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 408
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. 407
Autoantibodies in inflammatory arthritis 400
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 398
Seronegative autoimmune diseases 398
The type I IFN system in rheumatoid arthritis 396
Identifying the cells breaching self-tolerance in autoimmunity. 392
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres 391
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 387
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. 385
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 384
Lymph node IL-18 expression in adult-onset Still's disease. 384
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 372
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 372
The interplay between inflammation and metabolism in rheumatoid arthritis 371
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 369
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 365
Insights on the role of physical activity in patients with rheumatoid arthritis 364
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 357
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 355
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate 349
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation 348
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 347
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. 341
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 317
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 316
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. 304
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 304
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 298
Histopathology of the skin in rheumatic diseases 298
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 293
null 287
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 277
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 272
Challenges in the treatment of Rheumatoid Arthritis 263
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 253
Interaction between microbiome and host genetics in psoriatic arthritis 236
Complement, infection, and autoimmunity 229
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 226
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 201
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 188
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 183
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 181
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 180
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 167
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 165
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 164
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 155
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 154
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 129
Severe lupus nephritis: an unexpected association with Fabry disease 128
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing 128
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 119
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 114
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 113
COVID-19: disCOVering the role of complement system 113
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 110
Gender equality in Rheumatology 107
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 104
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 103
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 97
Tackling the autoimmune side in Spondyloarthritis: a systematic review 97
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 83
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 54
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 41
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 34
Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome 34
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 34
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE 34
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 33
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 33
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 28
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib 28
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 26
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 26
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 25
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 25
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study 24
The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors 24
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 23
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 23
The steroid-sparing effect of JAK inhibitors across multiple patient populations 23
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 22
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 21
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 21
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 19
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 19
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 19
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease 19
Totale 21.977
Categoria #
all - tutte 52.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.645


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.323 0 0 0 0 447 748 514 563 588 599 426 438
2020/20214.731 440 589 507 552 570 498 612 479 186 115 139 44
2021/2022856 37 82 75 58 29 50 40 48 46 66 94 231
2022/20231.178 108 99 40 139 103 259 108 89 116 23 66 28
2023/2024593 60 17 22 15 68 133 15 87 26 19 43 88
2024/20251.194 89 556 367 158 24 0 0 0 0 0 0 0
Totale 22.120